PBH
Prestige Consumer Healthcare Inc.
Healthcare · Drug Manufacturers - Specialty & Generic · NYQ
$47.18
Data: 2026-05-28
✓ ETHICAL PASS

Unknown MOAT
HIGH
Data Confidence: 100.0%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$2.3B
Total market value of the company
12.35
Reasonably valued
9.52
Based on estimated future earnings — lower means cheaper
Rev Growth
-5.0%
Year-over-year revenue change
Profit Margin
17.5%
How much profit the company keeps from each dollar of revenue
10.2%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$70.00
+48% from current price — median analyst estimate
Recommendation
BUY
Consensus view from 5 analysts covering this stock
About Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

https://www.prestigebrands.com

Country: United States Employees: 890 Industry: Drug Manufacturers - Specialty & Generic
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
0.0% N/A
Debt must be below 33% of total assets
Cash Ratio
0.0% N/A
Interest-bearing cash below 33% of assets
Receivables
0.0% N/A
Receivables below 49% of assets
Revenue Purity
0.0% PASS
Non-compliant revenue below 5% — any excess requires purification
Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

DISTRIBUTION
Smart money appears to be selling into strength — caution
-0.315
Returns do not compensate for the risk — negative edge
-0.0352
No positive edge detected — the data suggests staying out
-0.250
Drawdown risk outweighs the returns — higher risk profile
Annual Return
-12.1%
Historical annualised return based on price data
-48.5%
Largest peak-to-trough decline — the worst it has been
BULL
Statistical model sees bullish momentum
Days in State
9
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

0.40
Very low correlation to market moves
52W High
$87.12
46% below the year high
52W Low
$42.62
11% above the year low
Avg Volume
617,565
Average daily shares traded — higher means easier to buy and sell
3.9
Days it would take all short sellers to cover — higher means more crowded
Short % Float
8.0%
Moderate short interest
N/A
Annual dividend as a percentage of the share price
$3.91
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

55.39
Heavy leverage — higher financial risk if revenues decline
3.57
Strong balance sheet — comfortably covers short-term obligations
Quick Ratio
2.12
Like current ratio but excludes inventory — stricter test
Gross Margin
55.7%
Revenue left after cost of goods — higher means pricing power
Operating Margin
26.8%
Profit from core operations before interest and tax
$193M
Positive — the business generates more cash than it spends
Revenue (TTM)
$1.1B
Total revenue over the last 12 months
Net Income
$190M
Profitable — the bottom line is positive
Analyst Coverage
Analysts
5
Target High
$75.00
Target Median
$70.00
Target Low
$50.00
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.